NCT00415740View on ClinicalTrials.gov

Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

May 31, 2006

Conditions

Healthy

Interventions

DRUG

ELC200 (carbidopa+levodopa+entacapone)

Trial Locations (1)

Unknown

Novartis Investigative Site, Nuremberg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY

NCT00415740 - Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers | Biotech Hunter | Biotech Hunter